نتائج البحث

المصدر: Powles , T , Burotto , M , Escudier , B , Apolo , A B , Bourlon , M T , Shah , A Y , Suárez , C , Porta , C , Barrios , C H , Richardet , M , Gurney , H , Kessler , E R , Tomita , Y , Bedke , J , George , S , Scheffold , C , Wang , P , Fedorov , V , Motzer , R J & Choueiri , T K 2024 , ' Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced ....

مصطلحات موضوعية: cabozantinib, IMDC, immunotherapy, nivolumab, phase III, renal cell carcinoma

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1016Test/j.esmoop.2024.102994
https://researchers.mq.edu.au/en/publications/b9267821-ffee-442b-87fc-1eb079ca0124Test
https://research-management.mq.edu.au/ws/files/340040848/Publisher_version_open_access_.pdfTest
http://www.scopus.com/inward/record.url?scp=85190795640&partnerID=8YFLogxKTest

View record in BASE

6

دورية أكاديمية

IO-Synthesise RCC: relationship between baseline health-related quality of life and clinical outcomes of nivolumab in patients with previously treated metastatic renal cell carcinoma using pooled real-world data from France and Germany

المؤلفون: Bedke, J., Thiery-Vuillemin, A., Grimm, M.O., Mueller-Huesmann, H., Ivanyi, P., von der Heyde, E., Barthélémy, P., Colomba, E., Albiges, L., Vano, Y.A., Ejzykowicz, F., Brellier, F., Herber, M., Grötzinger, S.W., Quentric, C., Bennett, B., Néré, S., Grünwald, V., Mouillet, G.

المصدر: European Urology Open Science ; volume 57, page S258-S259 ; ISSN 2666-1683

مصطلحات موضوعية: Urology

الإتاحة: https://doi.org/10.1016/s2666-1683Test(23)01476-3
https://api.elsevier.com/content/article/PII:S2666168323014763?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666168323014763?httpAccept=text/plainTest

View record in BASE

7

دورية أكاديمية

Tumor Response by Baseline Metastases in Patients (Pts) With Renal Cell Carcinoma (RCC) Treated with Lenvatinib (L) Plus Pembrolizumab (P) vs Sunitinib (S): Post Hoc Analysis of the CLEAR Trial

المؤلفون: Grünwald, V., McKay, R.R., Buchler, T., Masatoshi, E., Park, S.H., Takagi, T., Zanetta, S., Keizman, D., Suárez, C., Négrier, S., Lee, J.L., Santini, D., Bedke, J., Staehler, M., Kollmannsberger, C., Choueiri, T., Motzer, R., Burgents, J., Okpara, C., Powles, T.

المصدر: European Urology Open Science ; volume 57, page S15-S16 ; ISSN 2666-1683

مصطلحات موضوعية: Urology

الإتاحة: https://doi.org/10.1016/s2666-1683Test(23)01307-1
https://api.elsevier.com/content/article/PII:S2666168323013071?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666168323013071?httpAccept=text/plainTest

View record in BASE

8

دورية أكاديمية

A molecularly characterized preclinical platform of subcutaneous renal cell carcinoma (RCC) patient-derived xenograft models to evaluate novel treatment strategies

المؤلفون: Gürgen, D., Becker, M., Dahlmann, M., Flechsig, S., Schaeffeler, E., Büttner, F.A., Schmees, C., Bohnert, R., Bedke, J., Schwab, M., Wendler, J.J., Schostak, M., Jandrig, B., Walther, W., Hoffmann, J.

مصطلحات موضوعية: Cancer Research, Topic 2: Molecular Processes and Therapies

وصف الملف: application/pdf

العلاقة: http://edoc.mdc-berlin.de/21757/1/21757oa.pdfTest; http://edoc.mdc-berlin.de/21757/2/21757suppl.pdfTest; A molecularly characterized preclinical platform of subcutaneous renal cell carcinoma (RCC) patient-derived xenograft models to evaluate novel treatment strategies. Gürgen, D. and Becker, M. and Dahlmann, M. and Flechsig, S. and Schaeffeler, E. and Büttner, F.A. and Schmees, C. and Bohnert, R. and Bedke, J. and Schwab, M. and Wendler, J.J. and Schostak, M. and Jandrig, B. and Walther, W. and Hoffmann, J. Frontiers in Oncology 12 : 889789. 21 June 2022

الإتاحة: https://doi.org/10.3389/fonc.2022.889789Test
http://edoc.mdc-berlin.de/21757Test/
https://edoc.mdc-berlin.de/21757Test/
http://edoc.mdc-berlin.de/21757/1/21757oa.pdfTest
http://edoc.mdc-berlin.de/21757/2/21757suppl.pdfTest

View record in BASE

9

دورية أكاديمية

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.

المؤلفون: Büttner, FA, Winter, S, Stühler, V, Rausch, S, Hennenlotter, J, Füssel, S, Zastrow, S, Meinhardt, M, Toma, M, Jerónimo, C, Henrique, R, Miranda-Gonçalves, V, Kröger, N, Ribback, S, Hartmann, A, Agaimy, A, Stöhr, C, Polifka, I, Fend, F, Scharpf, M, Comperat, E, Wasinger, G, Moch, H, Stenzl, A, Gerlinger, M, Bedke, J, Schwab, M, Schaeffeler, E

المساهمون: Gerlinger, Marco

مصطلحات موضوعية: Cancer-specific survival, Gene expression deconvolution, Immunotherapy, RCC subtypes, Renal cell carcinoma, B7-H1 Antigen, Carcinoma, Renal Cell, Humans, Kidney Neoplasms, Prognosis, Sunitinib

جغرافية الموضوع: England

وصف الملف: Electronic; application/pdf

العلاقة: ARTN 105; Genome Medicine: medicine in the post-genomic era, 2022, 14 (1), pp. 105 -; https://repository.icr.ac.uk/handle/internal/5603Test

الإتاحة: https://doi.org/10.1186/s13073-022-01105-yTest
https://repository.icr.ac.uk/handle/internal/5603Test

View record in BASE

النص الكامل